Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.82−0.02 (-1.09%)
Close on Nov 17, 2026Market cap $565.71MP/E –Yield 0.00%
Pacific Biosciences of California price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Pacific Biosciences of California's price to book ratio was 183.7× on Jul 31, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 0.6× to 220.5×, with a median of 3.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 183.7× | +168.1 |
| 2025 | Dec 31, 2025 | 15.6× | +14.5 |
| 2024 | Dec 31, 2024 | 1.1× | −2.2 |
| 2023 | Dec 29, 2023 | 3.3× | +0.4 |
| 2022 | Dec 30, 2022 | 2.9× | −2.4 |
| 2021 | Dec 31, 2021 | 5.4× | −30.7 |
| 2020 | Dec 31, 2020 | 36.0× | +20.6 |
| 2019 | Dec 31, 2019 | 15.4× | +7.1 |
| 2018 | Dec 31, 2018 | 8.4× | +5.3 |
| 2017 | Dec 29, 2017 | 3.0× | −0.5 |
| 2016 | Dec 30, 2016 | 3.6× | −20.5 |
| 2015 | Dec 31, 2015 | 24.0× | +13.5 |
| 2014 | Dec 31, 2014 | 10.5× | +6.4 |
| 2013 | Dec 31, 2013 | 4.1× | +3.4 |
| 2012 | Dec 31, 2012 | 0.7× | +0.0 |
| 2011 | Dec 30, 2011 | 0.7× | – |
See a number that looks wrong?